| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |